Prospective trial of different antimicrobial treatment durations for presumptive canine urinary tract infections

BMC Vet Res. 2021 Sep 6;17(1):299. doi: 10.1186/s12917-021-02974-y.

Abstract

Background: Avoidance of unnecessary antimicrobial administration is a key tenet of antimicrobial stewardship; knowing the optimal duration of therapy obviates over-treatment. However, little research has been performed to establish course lengths for common canine infections. In clinical practice, antimicrobial therapy is frequently prescribed in dogs presenting lower urinary tract signs (haematuria, pollakiuria and dysuria/stranguria). The proposed length of treatment in International Consensus guidelines has decreased with each iteration, but these recommendations remain arbitrary and largely extrapolated from experience in people.

Methods: The objective of this prospective, multi-centre study is to find the shortest course duration that is non-inferior to the standard duration of 7 days of amoxicillin/clavulanate in terms of clinical outcomes for female dogs with lower urinary tract signs consistent with a urinary tract infection. An electronic data capture platform will be used by participating veterinarians working in clinical practice in the United Kingdom. Eligible dogs must be female, aged between 6 months and 10 years and have lower urinary tract signs of up to seven days' duration. Enrolment will be offered in cases where the case clinician intends to prescribe antimicrobial therapy. Automatic pseudo-randomisation to treatment group will be based on the day of presentation (Monday-Friday); all antimicrobial courses will be completed on the Sunday after presentation generating different treatment durations. Follow-up data will be collected 1, 8 and 22-26 days after completion of the antimicrobial course to ensure effective safety netting, and to monitor short-term outcome and recurrence rates. Informed owner consent will be obtained in all cases. The study is approved by the Ethical Review Board of the University of Nottingham and has an Animal Test Certificate from the Veterinary Medicine's Directorate.

Discussion: This study has been designed to mirror current standards of clinical management; conclusions should therefore, be widely applicable and guide practising veterinarians in their antimicrobial decision-making process. A duration-response curve will be created allowing determination of the optimal treatment duration for the management of female dogs with lower urinary tract signs. It is hoped that these results will contribute valuable information to improve future antimicrobial stewardship as part of a wider one-health perspective.

Keywords: Antimicrobial resistance; Antimicrobial stewardship; Canine; Duration-response curve; Urinary tract infection; duration.

Publication types

  • Multicenter Study

MeSH terms

  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use*
  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Dog Diseases / drug therapy*
  • Dogs
  • Duration of Therapy
  • Female
  • Prospective Studies
  • United Kingdom
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / veterinary*

Substances

  • Anti-Bacterial Agents
  • Amoxicillin-Potassium Clavulanate Combination